Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Health and Quality of Life Outcomes
|
July 13, 2024
Scale and rate heterogeneity in the EQ-5D-5L valuation
Maksat Jumamyradov, Benjamin M Craig, Michał Jakubczyk
Medical Care
|
August 22, 2025
Revisiting the Valuation of Child Health-Related Quality of Life: Replacing Paired Comparisons With Kaizen Tasks and QALY Scaling With Experience Scaling
Maksat Jumamyradov, Benjamin M Craig, Michał Jakubczyk
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 25, 2020
Ranking the Criteria Used in the Appraisal of Drugs for Reimbursement: A Stated Preferences Elicitation With Health Technology Assessment Stakeholders Across Jurisdictional Contexts
Wiesława Dominika Wranik, Michał Jakubczyk, Krzysztof Drachal
Surgery
|
July 31, 2020
Outcomes of ex vivo liver resection and autotransplantation: A systematic review and meta-analysis
Michał Zawistowski, Joanna Nowaczyk, Michał Jakubczyk, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
August 21, 2015
Economic resources consumption structure in severe hypoglycemia episodes: a systematic review and meta-analysis
Michał Jakubczyk, Elżbieta Rdzanek, Maciej Niewada, et al.
Pharmacoeconomics
|
June 5, 2019
Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe
Dominik Golicki, Michał Jakubczyk, Katarzyna Graczyk, et al.
Value in Health Regional Issues
|
April 29, 2018
What Influences Recommendations Issued by the Agency for Health Technology Assessment in Poland? A Glimpse Into Decision Makers' Preferences
Maciej Niewada, Małgorzata Polkowska, Michał Jakubczyk, et al.
Pharmacoeconomics
|
February 26, 2025
Making Composite Time Trade-Off Sensitive for Worse-than-Dead Health States
Michał Jakubczyk, Bram Roudijk, Stefan A Lipman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 1, 2023
This Dead or That Dead: Framing Effects in the Evaluation of Health States
Michał Jakubczyk, Paul Schneider, Stefan A Lipman, et al.
Acta Crystallographica. Section E, Structure Reports Online
|
April 28, 2011
5-Fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol
Izabela D Madura, Agnieszka Adamczyk-Woźniak, Michał Jakubczyk, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Health and Quality of Life Outcomes
|
July 13, 2024
Scale and rate heterogeneity in the EQ-5D-5L valuation
Maksat Jumamyradov, Benjamin M Craig, Michał Jakubczyk
Medical Care
|
August 22, 2025
Revisiting the Valuation of Child Health-Related Quality of Life: Replacing Paired Comparisons With Kaizen Tasks and QALY Scaling With Experience Scaling
Maksat Jumamyradov, Benjamin M Craig, Michał Jakubczyk
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 25, 2020
Ranking the Criteria Used in the Appraisal of Drugs for Reimbursement: A Stated Preferences Elicitation With Health Technology Assessment Stakeholders Across Jurisdictional Contexts
Wiesława Dominika Wranik, Michał Jakubczyk, Krzysztof Drachal
Surgery
|
July 31, 2020
Outcomes of ex vivo liver resection and autotransplantation: A systematic review and meta-analysis
Michał Zawistowski, Joanna Nowaczyk, Michał Jakubczyk, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
August 21, 2015
Economic resources consumption structure in severe hypoglycemia episodes: a systematic review and meta-analysis
Michał Jakubczyk, Elżbieta Rdzanek, Maciej Niewada, et al.
Pharmacoeconomics
|
June 5, 2019
Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe
Dominik Golicki, Michał Jakubczyk, Katarzyna Graczyk, et al.
Value in Health Regional Issues
|
April 29, 2018
What Influences Recommendations Issued by the Agency for Health Technology Assessment in Poland? A Glimpse Into Decision Makers' Preferences
Maciej Niewada, Małgorzata Polkowska, Michał Jakubczyk, et al.
Pharmacoeconomics
|
February 26, 2025
Making Composite Time Trade-Off Sensitive for Worse-than-Dead Health States
Michał Jakubczyk, Bram Roudijk, Stefan A Lipman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 1, 2023
This Dead or That Dead: Framing Effects in the Evaluation of Health States
Michał Jakubczyk, Paul Schneider, Stefan A Lipman, et al.
Acta Crystallographica. Section E, Structure Reports Online
|
April 28, 2011
5-Fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol
Izabela D Madura, Agnieszka Adamczyk-Woźniak, Michał Jakubczyk, et al.
Page
of 5